We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
-0.61%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$49.4B
AUM Growth
+$362M
Cap. Flow
+$946M
Cap. Flow %
1.92%
Top 10 Hldgs %
16.58%
Holding
3,469
New
172
Increased
1,694
Reduced
1,283
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 11.79%
2 Financials 6.88%
3 Healthcare 6%
4 Consumer Discretionary 5.78%
5 Industrials 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
3176
PUT
Freeport-McMoran
FCX
$96.9B
$56K ﹤0.01%
+24,700
New +$870K
IMDX
3177
Insight Molecular Diagnostics
IMDX
$140M
$56K ﹤0.01%
+787
New +$72.3K
ORC
3178
Orchid Island Capital
ORC
$1.32B
$56K ﹤0.01%
2,272
+85
+4% +$2.14K
EGIO
3179
DELISTED
Edgio, Inc. Common Stock
EGIO
$56K ﹤0.01%
585
-6
-1% -$632
ROI
3180
DELISTED
RiskOn International, Inc. Common Stock
ROI
$56K ﹤0.01%
+358
New +$50.2K
BGMS
3181
Bio Green Med Solution Inc
BGMS
$4.97M
$53K ﹤0.01%
3
-14
-82% -$269K
SVVC
3182
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$52K ﹤0.01%
11,000
CRVO icon
3183
CervoMed
CRVO
$41M
$51K ﹤0.01%
1,333
ADAM
3184
Adamas Trust
ADAM
$910M
$48K ﹤0.01%
2,790
-1,732
-38% -$30.1K
TH icon
3185
Target Hospitality
TH
$1.66B
$48K ﹤0.01%
13,000
UAVS icon
3186
AgEagle Aerial Systems
UAVS
$55.5M
$46K ﹤0.01%
+15
New +$55.7K
MRK icon
3187
CALL
Merck
MRK
$327B
$45K ﹤0.01%
32,400
+1,800
+6% +$137K
TCRT icon
3188
Alaunos Therapeutics
TCRT
$4.79M
$44K ﹤0.01%
163
+31
+23% +$9.48K
BCLI
3189
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$42K ﹤0.01%
849
-16
-2% -$842
CVS icon
3190
CALL
CVS Health
CVS
$120B
$40K ﹤0.01%
12,200
-14,500
-54% -$1.21M
F icon
3191
CALL
Ford
F
$55.2B
$40K ﹤0.01%
38,000
-11,800
-24% -$161K
CBAY
3192
DELISTED
Cymabay Therapeutics
CBAY
$40K ﹤0.01%
11,091
-4,829
-30% -$19K
ARTW icon
3193
Arts-Way Manufacturing Co
ARTW
$14.2M
$39K ﹤0.01%
10,703
REFR icon
3194
Research Frontiers
REFR
$17.1M
$39K ﹤0.01%
15,155
TAST
3195
DELISTED
Carrols Restaurant Group, Inc.
TAST
$39K ﹤0.01%
+10,746
New +$48K
EVRI
3196
CALL
DELISTED
Everi Holdings
EVRI
$38K ﹤0.01%
11,500
ASXC
3197
DELISTED
Asensus Surgical, Inc.
ASXC
$37K ﹤0.01%
19,857
-6,395
-24% -$14.4K
IFRX icon
3198
InflaRx
IFRX
$295M
$36K ﹤0.01%
13,888
-9,458
-41% -$24.9K
LCTX icon
3199
Lineage Cell Therapeutics
LCTX
$278M
$36K ﹤0.01%
14,361
-2
-0% -$5
AWH
3200
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$36K ﹤0.01%
733

Similar funds

Raymond James Financial Services Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James Financial Services Advisors held 3,469 positions worth $49.4B, up 0.74% from $49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James Financial Services Advisors's Q3 2021 filing shows 172 new, 1,694 increased, 1,283 reduced and 185 closed positions. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 1,219,156 shares worth $31.6M. The largest sale was Chevron, an estimated $73.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James Financial Services Advisors's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 1,219,156 shares worth $31.6M.
  • Raymond James Financial Services Advisors added most to Darden Restaurants in Q3 2021, an estimated $72.9M increase.
  • Raymond James Financial Services Advisors's biggest Q3 2021 reduction was Chevron, cutting an estimated $73.7M.
  • Raymond James Financial Services Advisors fully exited State Street SPDR Portfolio Europe ETF in Q3 2021, selling an estimated $22.3M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 17% of its $49.4B portfolio in Q3 2021.
  • Raymond James Financial Services Advisors opened 172 new positions and closed 185 in Q3 2021.
  • Raymond James Financial Services Advisors's portfolio value rose 0.74% quarter-over-quarter to $49.4B.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.